← Back to catalogue

Reliefband® Conductivity Gel

FDA UDI

Class II (US FDA UDI)

by ReliefBand Technologies

Identity

Trade Name
Reliefband® Conductivity Gel FDA UDI
Generic Name
Anti-nausea transcutaneous electrical nerve stimulation wristband FDA UDI
Device Name
Reliefband Conductivity Gel for use with Reliefband devices. Each tube contains 7.5 mL (0.25 oz) of hypoallergenic conductivity gel. Reliefband Conductivity Gel improves effectiveness of Reliefband devices, keeping nerve stimulation active to control nausea and vomiting associated with motion sickness, morning sickness, chemotherapy and postoperative. FDA UDI
Model / Reference
GP-1 FDA UDI
Description
Reliefband Conductivity Gel for use with Reliefband devices. Each tube contains 7.5 mL (0.25 oz) of hypoallergenic conductivity gel. Reliefband Conductivity Gel improves effectiveness of Reliefband devices, keeping nerve stimulation active to control nausea and vomiting associated with motion sickness, morning sickness, chemotherapy and postoperative. FDA UDI

Identifiers

Catalog Number
GP-1 FDA UDI
Primary DI / UDI-DI
00661168190011 FDA UDI
FDA Product Code
GZJ FDA UDI
GMDN Term
Anti-nausea transcutaneous electrical nerve stimulation wristband FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.5890 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Anti-nausea transcutaneous electrical nerve stimulation wristband

Reliefband® Conductivity Gel by ReliefBand Technologies — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Anti-nausea transcutaneous electrical nerve stimulation wristband.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
ReliefBand Technologies

Sources (1)

  • FDA UDI 09858be8-7784-4960-854c-8e0d036b48d6 35 fields · synced Jun 8, 2026